← FDA DRUG APPROVALS

FDA ANDA · ANDA090637

ALLOPURINOL

Sponsor: IPCA LABS LTD

APPLICATION
ANDA090637
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-16
LATEST ACTION
2024-01-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ALLOPURINOLDiscontinued
ALLOPURINOL 100MG · TABLET · ORAL
ALLOPURINOLDiscontinued
ALLOPURINOL 300MG · TABLET · ORAL

Approval history

2024-01-29Labeling · Supplement 6 · standardAP
2019-07-30Labeling · Supplement 4 · standardAP
2011-03-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →